LYNDA HAIDAR-AHMAD: Open Payments
NPI 1831366145 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 18 payments from 9 companies in 2025. Trend: 2023 $163 · 2024 $215 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $157 |
| Novo Nordisk Inc | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Travere Therapeutics, Inc. | 1 | $28 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
Products named: JARDIANCE, Wegovy, FARXIGA, IDACIO, FUROSCIX, Vanrafia, ELFABRIO.
Industry payments across MI — which companies pay providers there.
